Pay in 4 interest-free payments of $5.48 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Can GLP-1 drugs benefit patients who are not obese
The future may involve: Sequencing and Combination: Using agents with complementary mechanisms (e.g., an incretin for weight loss combined with a myostatin inhibitor for lean mass preservation)
Associate Professor Piya is an Academic Endocrinologist at the School of Medicine, Western Sydney University as well as Head of Department for the Macarthur Diabetes Endocrinology and Metabolism Service at Campbelltown and Camden Hospitals, South Western Sydney Local Health District, NSW
PMID: 16278749
US$ 28.83
US$ 26.02
US$ 28.04
US$ 12250.00
Sold : Login>>
